RFA-HL-23-014 - Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Application Due Date Changes for RFA-HL-23-014, "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33)" | NOT-HL-22-019 | NHLBI | Mar 24, 2022 | Apr 15, 2026 | R33 |
For technical issues E-mail OER Webmaster